PowerShow.com
  • Help
  • Preferences
  • Sign up
  • Log in
Advanced
Free template

Taxus PowerPoint PPT Presentations

Grid List
All Time
All TimeAdded TodayAdded This WeekAdded This Month
Show:
Recommended
RecommendedRelevanceLatestHighest RatedMost Viewed
Sort by:
Featured Presentations
Search Results
TAXUS Express to TAXUS Libert PowerPoint PPT Presentation
TAXUS Express to TAXUS Libert - Uniformed Services University of the Health Sciences. Bethesda, Maryland. Disclosures ... The following relationships exist related to Boston Scientific ...
Uniformed Services University of the Health Sciences. Bethesda, Maryland. Disclosures ... The following relationships exist related to Boston Scientific ...
| PowerPoint PPT presentation | free to download
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent PowerPoint PPT Presentation
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent - Title: TAXUS Slow Release Data Author: C. Michael Gibson, M.S., M.D. Last modified by: mgibson Created Date: 5/18/1999 8:41:19 PM Document presentation format
Title: TAXUS Slow Release Data Author: C. Michael Gibson, M.S., M.D. Last modified by: mgibson Created Date: 5/18/1999 8:41:19 PM Document presentation format
| PowerPoint PPT presentation | free to download
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent PowerPoint PPT Presentation
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent - TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent Presented at TCT 2002 TAXUS II: Study Overview ...
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent Presented at TCT 2002 TAXUS II: Study Overview ...
| PowerPoint PPT presentation | free to download
TAXUS II: Moderate Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM MR Stent PowerPoint PPT Presentation
TAXUS II: Moderate Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM MR Stent - TAXUS II: Moderate Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM MR Stent Presented at TCT 2002 TAXUS II: Study Overview ...
TAXUS II: Moderate Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM MR Stent Presented at TCT 2002 TAXUS II: Study Overview ...
| PowerPoint PPT presentation | free to download
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent PowerPoint PPT Presentation
TAXUS II: Slow Release Formula An International, Randomized, Multicenter, Blinded Trial of TAXUSTM NIRxTM SR Stent - TAXUSTM NIRxTM SR (n=267) TAXUSTM NIRxTM MR (n=269) 30 day, 6 month, 1-5 year F/U ... Slow Release (SR) Moderate Release (MR) 30 Day Follow-up. 6 Month Follow ...
TAXUSTM NIRxTM SR (n=267) TAXUSTM NIRxTM MR (n=269) 30 day, 6 month, 1-5 year F/U ... Slow Release (SR) Moderate Release (MR) 30 Day Follow-up. 6 Month Follow ...
| PowerPoint PPT presentation | free to download
TAXUS PERSEUS  A Novel Platinum Chromium, Thin-Strut TAXUS Element Stent for the Treatment of de novo Coronary Stenoses PowerPoint PPT Presentation
TAXUS PERSEUS A Novel Platinum Chromium, Thin-Strut TAXUS Element Stent for the Treatment of de novo Coronary Stenoses - TAXUS PERSEUS A Novel Platinum Chromium, Thin-Strut TAXUS Element Stent for the Treatment of de novo Coronary Stenoses Dean J. Kereiakes, MD; Louis A. Cannon, MD
TAXUS PERSEUS A Novel Platinum Chromium, Thin-Strut TAXUS Element Stent for the Treatment of de novo Coronary Stenoses Dean J. Kereiakes, MD; Louis A. Cannon, MD
| PowerPoint PPT presentation | free to download
Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial PowerPoint PPT Presentation
Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial - Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial
Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial
| PowerPoint PPT presentation | free to download
Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial PowerPoint PPT Presentation
Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized Trial - Mary E. Russell, MD Gregg W. Stone, MD Stephen G. Ellis, MD. Executive Committee ... Max. Infl. Pressure (atm) P value. TAXUS. n=577. Procedural Characteristics ...
Mary E. Russell, MD Gregg W. Stone, MD Stephen G. Ellis, MD. Executive Committee ... Max. Infl. Pressure (atm) P value. TAXUS. n=577. Procedural Characteristics ...
| PowerPoint PPT presentation | free to download
??? ????? taxus ?? ??? ???? ????? ?????? ???. PowerPoint PPT Presentation
??? ????? taxus ?? ??? ???? ????? ?????? ???. -
| PowerPoint PPT presentation | free to view
TAXUS WOMAN PowerPoint PPT Presentation
TAXUS WOMAN - TAXUS WOMAN A Pooled Analysis of Outcomes with Paclitaxel-eluting Stents in Women and Men Simon Corbett Interventional Fellow St Mary s Hospital
TAXUS WOMAN A Pooled Analysis of Outcomes with Paclitaxel-eluting Stents in Women and Men Simon Corbett Interventional Fellow St Mary s Hospital
| PowerPoint PPT presentation | free to download
The TAXUS PowerPoint PPT Presentation
The TAXUS - Title: Symposia Speaker Binder Author: LEIGH HUTCHINSON Last modified by: C. Michael Gibson, M.S., M.D. Created Date: 4/11/2003 7:11:16 PM Document presentation format
Title: Symposia Speaker Binder Author: LEIGH HUTCHINSON Last modified by: C. Michael Gibson, M.S., M.D. Created Date: 4/11/2003 7:11:16 PM Document presentation format
| PowerPoint PPT presentation | free to download
The TAXUS PowerPoint PPT Presentation
The TAXUS - The TAXUS Paclitaxel-Eluting Stent Program Table of Contents Drug-eluting stent overview Drug-eluting stent benefits In your opinion Part 1 Consistently low ...
The TAXUS Paclitaxel-Eluting Stent Program Table of Contents Drug-eluting stent overview Drug-eluting stent benefits In your opinion Part 1 Consistently low ...
| PowerPoint PPT presentation | free to download
CYPHER Vs TAXUS PowerPoint PPT Presentation
CYPHER Vs TAXUS - CYPHER Vs TAXUS. A Comparison of SIRIUS and TAXUS IV results. CYPHER Vs TAXUS. CYPHER Vs TAXUS ... Use of GP IIb /IIIa inhibitors. CYPHER Vs TAXUS. CYPHER Vs ...
CYPHER Vs TAXUS. A Comparison of SIRIUS and TAXUS IV results. CYPHER Vs TAXUS. CYPHER Vs TAXUS ... Use of GP IIb /IIIa inhibitors. CYPHER Vs TAXUS. CYPHER Vs ...
| PowerPoint PPT presentation | free to download
TAXUS II and IV: two-year follow-up PowerPoint PPT Presentation
TAXUS II and IV: two-year follow-up - Paclitaxel-eluting stent Slow-release formulation n=662 Paclitaxel-eluting stent Slow-release formulation n=131 Moderate-release formulation n=135 Bare Stent n= 652
Paclitaxel-eluting stent Slow-release formulation n=662 Paclitaxel-eluting stent Slow-release formulation n=131 Moderate-release formulation n=135 Bare Stent n= 652
| PowerPoint PPT presentation | free to download
CYPHER Vs TAXUS PowerPoint PPT Presentation
CYPHER Vs TAXUS - Drug-eluting stents have emerged as a potential solution for the prevention ... up angiography with qualitative coronary angioplasty is being performed in all ...
Drug-eluting stents have emerged as a potential solution for the prevention ... up angiography with qualitative coronary angioplasty is being performed in all ...
| PowerPoint PPT presentation | free to download
The Science Behind Taxus PowerPoint PPT Presentation
The Science Behind Taxus - The Science Behind Taxus Advanced Angioplasty 2004 Christian Vander Velde, Boston Scientific Europe, Marketing TAXUS Technology Binds tubulin Microtubular dynamics ...
The Science Behind Taxus Advanced Angioplasty 2004 Christian Vander Velde, Boston Scientific Europe, Marketing TAXUS Technology Binds tubulin Microtubular dynamics ...
| PowerPoint PPT presentation | free to view
A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction PowerPoint PPT Presentation
A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction - HORIZONS AMI Trial A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction
HORIZONS AMI Trial A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction
| PowerPoint PPT presentation | free to download
Stent TAXUS Superioridad en Diabticos PowerPoint PPT Presentation
Stent TAXUS Superioridad en Diabticos - TAXUS Supervivencia Libre de Eventos a 4 a os en el subgrupo de Diab ticos ... Cypher : Supervivencia libre de eventos a 4 a os. Subgrupo Pacientes Diab ticos ...
TAXUS Supervivencia Libre de Eventos a 4 a os en el subgrupo de Diab ticos ... Cypher : Supervivencia libre de eventos a 4 a os. Subgrupo Pacientes Diab ticos ...
| PowerPoint PPT presentation | free to view
Cost Effectiveness of PaclitaxelEluting vs Bare Metal Stents: TAXUSIV PowerPoint PPT Presentation
Cost Effectiveness of PaclitaxelEluting vs Bare Metal Stents: TAXUSIV - Cost Effectiveness of Paclitaxel-Eluting vs Bare Metal Stents: TAXUS-IV. Adapted from ... To quantify the net 1-year medical costs and cost effectiveness of patients ...
Cost Effectiveness of Paclitaxel-Eluting vs Bare Metal Stents: TAXUS-IV. Adapted from ... To quantify the net 1-year medical costs and cost effectiveness of patients ...
| PowerPoint PPT presentation | free to view
TAXUS ATLAS WORKHORSE and DIRECT STENT First Report of Nine-and Twelve Month Clinical and Angiographic Results PowerPoint PPT Presentation
TAXUS ATLAS WORKHORSE and DIRECT STENT First Report of Nine-and Twelve Month Clinical and Angiographic Results - TAXUS ATLAS WORKHORSE and DIRECT STENT First Report of Nine-and Twelve Month Clinical and Angiographic Results Mark A. Turco, MD, FACC And John A. Ormiston, MBChB
TAXUS ATLAS WORKHORSE and DIRECT STENT First Report of Nine-and Twelve Month Clinical and Angiographic Results Mark A. Turco, MD, FACC And John A. Ormiston, MBChB
| PowerPoint PPT presentation | free to download
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study  One Year Results of the PCI and CABG Registries PowerPoint PPT Presentation
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries - The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries
| PowerPoint PPT presentation | free to download
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX St PowerPoint PPT Presentation
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX St - The Synergy between Percutaneous Coronary Intervention with TAXUS and ... Acute MI with CPK 2x. Concomitant cardiac surgery. SYNTAX: Left Main Subset Serruys ...
The Synergy between Percutaneous Coronary Intervention with TAXUS and ... Acute MI with CPK 2x. Concomitant cardiac surgery. SYNTAX: Left Main Subset Serruys ...
| PowerPoint PPT presentation | free to view
The SYNTAX Trial: SYNergy between PCI with TAXUS and cardiac surgery Trial Design and Philosophy PowerPoint PPT Presentation
The SYNTAX Trial: SYNergy between PCI with TAXUS and cardiac surgery Trial Design and Philosophy - SYNergy between PCI with TAXUS and cardiac surgery. Trial Design ... Gibbon performs 1st successful open heart surgery using a cardio-pulmonary bypass machine ...
SYNergy between PCI with TAXUS and cardiac surgery. Trial Design ... Gibbon performs 1st successful open heart surgery using a cardio-pulmonary bypass machine ...
| PowerPoint PPT presentation | free to view
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX St PowerPoint PPT Presentation
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX St - During the present decade, major developments in CABG (e. ... Didier Carrie. Arnaud Farge. Marie-Claude Morice. Jean-Paul Bessou. Jacques Berland. Patrick Soula ...
During the present decade, major developments in CABG (e. ... Didier Carrie. Arnaud Farge. Marie-Claude Morice. Jean-Paul Bessou. Jacques Berland. Patrick Soula ...
| PowerPoint PPT presentation | free to view
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study  One Year Results of the PCI and CABG Registries PowerPoint PPT Presentation
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries - The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX St
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX St
| PowerPoint PPT presentation | free to download
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study  Primary Endpoint Results at One Year in the Randomized Cohort PowerPoint PPT Presentation
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study Primary Endpoint Results at One Year in the Randomized Cohort - Title: Title of Presentation -subtitle or supporting statement- Author: Keith D Dawkins MD Last modified by: C. Michael Gibson Created Date: 8/12/2008 9:38:28 PM
Title: Title of Presentation -subtitle or supporting statement- Author: Keith D Dawkins MD Last modified by: C. Michael Gibson Created Date: 8/12/2008 9:38:28 PM
| PowerPoint PPT presentation | free to download
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study  One Year Results of the PCI and CABG Registries PowerPoint PPT Presentation
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries - The SYNTAX Study. One Year Results of the PCI and CABG Registries. Friedrich W. Mohr MD PhD ... 20% of patient data at each site (every fifth patient) was fully ...
The SYNTAX Study. One Year Results of the PCI and CABG Registries. Friedrich W. Mohr MD PhD ... 20% of patient data at each site (every fifth patient) was fully ...
| PowerPoint PPT presentation | free to download
FDA Panel on Drug-eluting Stent Safety December 7 and 8th, 2006  Boston Scientific Presentation: Part I On-label Use of the TAXUS
FDA Panel on Drug-eluting Stent Safety December 7 and 8th, 2006 Boston Scientific Presentation: Part I On-label Use of the TAXUS
FDA Panel on Drug-eluting Stent Safety December 7 and 8th, 2006  Boston Scientific Presentation: Part II Real-world use of the TAXUS
FDA Panel on Drug-eluting Stent Safety December 7 and 8th, 2006 Boston Scientific Presentation: Part II Real-world use of the TAXUS - ... Index Procedure. Simple Lesion ... Years Since Index Procedure. Complex (N=4, ... Years Since Index Procedure. Historical CABG. Historical CABG and PCI ...
... Index Procedure. Simple Lesion ... Years Since Index Procedure. Complex (N=4, ... Years Since Index Procedure. Historical CABG. Historical CABG and PCI ...
Snijmaterialen PowerPoint PPT Presentation
Snijmaterialen - ... baccata Taxus snijmaterialen niveau 2 8 Dracaena sanderiana Lucky Bamboo Lucky Bamboe snijmaterialen niveau 2 9 Cucurbita pepo Sierkalabas ...
... baccata Taxus snijmaterialen niveau 2 8 Dracaena sanderiana Lucky Bamboo Lucky Bamboe snijmaterialen niveau 2 9 Cucurbita pepo Sierkalabas ...
| PowerPoint PPT presentation | free to download
In free-sporing tracheophytes, the dispersal unit is the spore (e.g., Dryopteris spore above), which germinates into a gametophyte-- so the haploid stage is dispersed for these plants. PowerPoint PPT Presentation
In free-sporing tracheophytes, the dispersal unit is the spore (e.g., Dryopteris spore above), which germinates into a gametophyte-- so the haploid stage is dispersed for these plants. - Pinaceae Pinus Picea Larix Abies Tsuga Cupressaceae Thuja Juniperus Taxaceae Taxus Pinaceae Pinus Picea Larix Abies Tsuga Cupressaceae Thuja Juniperus Taxaceae Taxus ...
Pinaceae Pinus Picea Larix Abies Tsuga Cupressaceae Thuja Juniperus Taxaceae Taxus Pinaceae Pinus Picea Larix Abies Tsuga Cupressaceae Thuja Juniperus Taxaceae Taxus ...
| PowerPoint PPT presentation | free to download
Safety of Drug Eluting Stents Do 2nd generation DES have a lower risk of stent thrombosis? PowerPoint PPT Presentation
Safety of Drug Eluting Stents Do 2nd generation DES have a lower risk of stent thrombosis? - Cypher/Taxus vs Endeavor. Cypher/Taxus vs Xience/Promus. Cypher vs Biomatrix. Cypher vs Yukon ... Endeavor II. Stent thrombosis ' ...
Cypher/Taxus vs Endeavor. Cypher/Taxus vs Xience/Promus. Cypher vs Biomatrix. Cypher vs Yukon ... Endeavor II. Stent thrombosis ' ...
| PowerPoint PPT presentation | free to view
Studying the roles of CABG and PCI using DES in the contemporary management of Left Main andor Three PowerPoint PPT Presentation
Studying the roles of CABG and PCI using DES in the contemporary management of Left Main andor Three - SYNTAX (SYNergy between PCI with TAXUS and cardiac surgery) TAXUS Express Stent System ... Off-pump surgery, % 15.0. Graft revascularization, % Complete ...
SYNTAX (SYNergy between PCI with TAXUS and cardiac surgery) TAXUS Express Stent System ... Off-pump surgery, % 15.0. Graft revascularization, % Complete ...
| PowerPoint PPT presentation | free to view
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - FAGGIO Fagus sylvatica TASSO Taxus baccata CERRO Quercus cerris LECCIO Quercus ilex ROVERELLA Quercus pubescens ACERO MINORE Acer monspessulanus ACERO CAMPESTRE Acer ...
FAGGIO Fagus sylvatica TASSO Taxus baccata CERRO Quercus cerris LECCIO Quercus ilex ROVERELLA Quercus pubescens ACERO MINORE Acer monspessulanus ACERO CAMPESTRE Acer ...
| PowerPoint PPT presentation | free to download
TAXUSNIRx Comparative Clinical - Version 3.02 PowerPoint PPT Presentation
TAXUSNIRx Comparative Clinical - Version 3.02 - TAXUS NIRx stent system. Slow and Moderate release Paclitaxel formulation. Dr Adrian Banning. John Radcliffe Hospital, Oxford. On behalf of the TAXUS II Investigators ...
TAXUS NIRx stent system. Slow and Moderate release Paclitaxel formulation. Dr Adrian Banning. John Radcliffe Hospital, Oxford. On behalf of the TAXUS II Investigators ...
| PowerPoint PPT presentation | free to download
COMPARE-AMI  Everolimus-eluting and Paclitaxel-eluting stents  for treatment of ST-elevation Myocardial Infarction Two-year clinical outcome PowerPoint PPT Presentation
COMPARE-AMI Everolimus-eluting and Paclitaxel-eluting stents for treatment of ST-elevation Myocardial Infarction Two-year clinical outcome - ... .0 %) Xience 3 (1.1%) 116 (42%) Taxus LM RCA Lesion distribution Drug-Eluting Stents Translute: hydro-carbon elastomer Fluoropolymer: ...
... .0 %) Xience 3 (1.1%) 116 (42%) Taxus LM RCA Lesion distribution Drug-Eluting Stents Translute: hydro-carbon elastomer Fluoropolymer: ...
| PowerPoint PPT presentation | free to download
Mustela erminea PowerPoint PPT Presentation
Mustela erminea - Mustela erminea. Mustela frenata. Mustela nivalis. Mustela vison. Taxidea taxus. Spilogale putorius. Mephitis mephitis. Lutra canadensis ...
Mustela erminea. Mustela frenata. Mustela nivalis. Mustela vison. Taxidea taxus. Spilogale putorius. Mephitis mephitis. Lutra canadensis ...
| PowerPoint PPT presentation | free to download
Comparison%20of%20the%20Efficacy%20and%20Safety%20of%20Zotarolimus-Eluting%20Stent%20vs.%20Sirolimus-Eluting%20Stent%20vs.%20PacliTaxel-Eluting%20Stent%20for%20Acute%20Myocardial%20Infarction%20Patients PowerPoint PPT Presentation
Comparison%20of%20the%20Efficacy%20and%20Safety%20of%20Zotarolimus-Eluting%20Stent%20vs.%20Sirolimus-Eluting%20Stent%20vs.%20PacliTaxel-Eluting%20Stent%20for%20Acute%20Myocardial%20Infarction%20Patients - The introduction of DESs (Cypher & Taxus) has greatly ... of zotarolimus, a low-profile cobalt alloy stent and a biocompatible phosphorylcholine polymer. ...
The introduction of DESs (Cypher & Taxus) has greatly ... of zotarolimus, a low-profile cobalt alloy stent and a biocompatible phosphorylcholine polymer. ...
| PowerPoint PPT presentation | free to download
Cancer Cure or Conservation? PowerPoint PPT Presentation
Cancer Cure or Conservation? - Cancer Cure or Conservation? Pacific Yew Taxus brevifolia Coniferous tree Shade tolerant In undisturbed stands is usually found as an understory tree Slow growing ...
Cancer Cure or Conservation? Pacific Yew Taxus brevifolia Coniferous tree Shade tolerant In undisturbed stands is usually found as an understory tree Slow growing ...
| PowerPoint PPT presentation | free to view
Mark A. Turco, MD, FACC, FSCAI Director, Center for Cardiac and Vascular Research Washington Adventist Hospital Takoma Park, Maryland PowerPoint PPT Presentation
Mark A. Turco, MD, FACC, FSCAI Director, Center for Cardiac and Vascular Research Washington Adventist Hospital Takoma Park, Maryland - TAXUS ATLAS SMALL VESSEL and LONG LESION First Report of Nine-Month Clinical and Angiographic Results Mark A. Turco, MD, FACC, FSCAI Director, Center for Cardiac and ...
TAXUS ATLAS SMALL VESSEL and LONG LESION First Report of Nine-Month Clinical and Angiographic Results Mark A. Turco, MD, FACC, FSCAI Director, Center for Cardiac and ...
| PowerPoint PPT presentation | free to download
Approach to Medical Therapy, PTCA, or Surgery in the Diabetic Patient PowerPoint PPT Presentation
Approach to Medical Therapy, PTCA, or Surgery in the Diabetic Patient - TAXUS Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma, MD
TAXUS Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma, MD
| PowerPoint PPT presentation | free to download
Mortalit PowerPoint PPT Presentation
Mortalit - 68 JNJ - .96 BSX. SIRTAX: 9 Month Results. Randomized Comparison of. CYPHER vs. TAXUS SIRTAX ... 1,012 patients with symptomatic coronary artery disease and ...
68 JNJ - .96 BSX. SIRTAX: 9 Month Results. Randomized Comparison of. CYPHER vs. TAXUS SIRTAX ... 1,012 patients with symptomatic coronary artery disease and ...
| PowerPoint PPT presentation | free to view
Plant Taxonomy: How Plants Are Named PowerPoint PPT Presentation
Plant Taxonomy: How Plants Are Named - The early scholars always wrote in Latin or Greek, so naturally, ... a plant occurs naturally (Anemone virginiana from Virginia, Taxus canadensis from Canada) ...
The early scholars always wrote in Latin or Greek, so naturally, ... a plant occurs naturally (Anemone virginiana from Virginia, Taxus canadensis from Canada) ...
| PowerPoint PPT presentation | free to view
Stent Thrombosis Following Primary PCI in STEMI: Predictors, Clinical Impact and Preventive Strategies from the Horizons AMI Trial PowerPoint PPT Presentation
Stent Thrombosis Following Primary PCI in STEMI: Predictors, Clinical Impact and Preventive Strategies from the Horizons AMI Trial - Primary PCI CABG Medical Rx ... thienopyridine R 1:1 3006 pts eligible for stent randomization R 3:1 Bare metal EXPRESS stent Paclitaxel-eluting TAXUS stent ...
Primary PCI CABG Medical Rx ... thienopyridine R 1:1 3006 pts eligible for stent randomization R 3:1 Bare metal EXPRESS stent Paclitaxel-eluting TAXUS stent ...
| PowerPoint PPT presentation | free to download
Purpose PowerPoint PPT Presentation
Purpose - SYNTAX: SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery ... previously had PCI or CABG, and needing concomitant surgery. ...
SYNTAX: SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery ... previously had PCI or CABG, and needing concomitant surgery. ...
| PowerPoint PPT presentation | free to view
Sin ttulo de diapositiva PowerPoint PPT Presentation
Sin ttulo de diapositiva - El Xilema es un tejido vascular cuya principal funci n es el ... Puede estar ausente como en Taxus. Solo en contacto con los conductos resin feros como en Pinus ...
El Xilema es un tejido vascular cuya principal funci n es el ... Puede estar ausente como en Taxus. Solo en contacto con los conductos resin feros como en Pinus ...
| PowerPoint PPT presentation | free to view
Otros valores destacados se adjuntan en el cuadro siguiente PowerPoint PPT Presentation
Otros valores destacados se adjuntan en el cuadro siguiente - Falla en la lesi n tratada (TLF) 0.03. 20.0. 14.3. TVF. p. Taxus ... Muerte (todas) % (n) 36 meses. n=130 pacientes. 131 lesiones. 24 meses. n=130 pacientes ...
Falla en la lesi n tratada (TLF) 0.03. 20.0. 14.3. TVF. p. Taxus ... Muerte (todas) % (n) 36 meses. n=130 pacientes. 131 lesiones. 24 meses. n=130 pacientes ...
| PowerPoint PPT presentation | free to download
Food and Drug Administration (FDA)
Food and Drug Administration (FDA) - ... no statistically significant difference in ST between TAXUS Stent and BMS ... BMS ARC All ST (Total) TAXUS ARC All ST (Total) 6 vs 1 ( 0.4%) Log-rank p = 0.06 ...
... no statistically significant difference in ST between TAXUS Stent and BMS ... BMS ARC All ST (Total) TAXUS ARC All ST (Total) 6 vs 1 ( 0.4%) Log-rank p = 0.06 ...
Pr PowerPoint PPT Presentation
Pr - Title: Pr sentation PowerPoint Author: Yannick Giraud Last modified by: Informatica Created Date: 5/22/2012 1:50:04 PM Document presentation format
Title: Pr sentation PowerPoint Author: Yannick Giraud Last modified by: Informatica Created Date: 5/22/2012 1:50:04 PM Document presentation format
| PowerPoint PPT presentation | free to download
The SPIRIT II Study - A Clinical Evaluation of the XIENCE PowerPoint PPT Presentation
The SPIRIT II Study - A Clinical Evaluation of the XIENCE - Clinical, Angiographic and IVUS 2 year results Patrick W. Serruys, MD, PhD Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands SCAI-ACCi2 Late-Breaking ...
Clinical, Angiographic and IVUS 2 year results Patrick W. Serruys, MD, PhD Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands SCAI-ACCi2 Late-Breaking ...
| PowerPoint PPT presentation | free to download
Slide Master PowerPoint PPT Presentation
Slide Master - EEL disruption. Inflammatory response. 20. Non-Clinical In Vivo Studies ... Stable EEL and luminal areas. Reflect medial remodeling. DHHS/FDA/CDRH. 24 ...
EEL disruption. Inflammatory response. 20. Non-Clinical In Vivo Studies ... Stable EEL and luminal areas. Reflect medial remodeling. DHHS/FDA/CDRH. 24 ...
| PowerPoint PPT presentation | free to download
Naalhoutgewassen (1) 321-340 B PowerPoint PPT Presentation
Naalhoutgewassen (1) 321-340 B - priemvormige bladeren in kransen . van 3, recht of iets naar buiten gebogen, korter. Sequoiadendron giganteum. Cryptomeria japonica. Overzicht Sequoiadendron-Cryptomeria
priemvormige bladeren in kransen . van 3, recht of iets naar buiten gebogen, korter. Sequoiadendron giganteum. Cryptomeria japonica. Overzicht Sequoiadendron-Cryptomeria
| PowerPoint PPT presentation | free to download
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions PowerPoint PPT Presentation
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions - ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische Universit t ...
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische Universit t ...
| PowerPoint PPT presentation | free to download
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents PowerPoint PPT Presentation
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents - Background. Restenosis occurring within a drug-eluting stent (DES) is a rare event. Optimal treatment strategies have not been identified and options range from ...
Background. Restenosis occurring within a drug-eluting stent (DES) is a rare event. Optimal treatment strategies have not been identified and options range from ...
| PowerPoint PPT presentation | free to download
The SPIRIT II Study - A Clinical Evaluation of the XIENCE PowerPoint PPT Presentation
The SPIRIT II Study - A Clinical Evaluation of the XIENCE - The SPIRIT II Study - A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary ...
The SPIRIT II Study - A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary ...
| PowerPoint PPT presentation | free to download
DrugEluting Stents in Diabetic Patients: MetaAnalysis of 8 Randomized Trials PowerPoint PPT Presentation
DrugEluting Stents in Diabetic Patients: MetaAnalysis of 8 Randomized Trials - Boyden et al. Am J Cardiol 2007;99:1399-1402. www.dave.md. Efficacy of DES in Diabetic Patients ... Boyden et al. Am J Cardiol 2007;99:1399-1402 ...
Boyden et al. Am J Cardiol 2007;99:1399-1402. www.dave.md. Efficacy of DES in Diabetic Patients ... Boyden et al. Am J Cardiol 2007;99:1399-1402 ...
| PowerPoint PPT presentation | free to view
Page of  


PowerPlugs
PowerPlugs
View by Category
Presentations
  • Photo Slideshows
  • Presentations (free-to-view)
    • Concepts & Trends
    • Entertainment
    • Fashion & Beauty
    • Government & Politics
    • How To, Education & Training
    • Medicine, Science & Technology
    • Other
    • Pets & Animals
    • Products & Services
    • Religious & Philosophical
    • Travel & Places
  • Presentations (pay-to-view)
Products Sold on our sister site CrystalGraphics.com
  • Ultimate Combo for PPT
  • PowerPoint Templates
  • Charts & Diagrams for PPT
  • 3D Character Slides
  • Background Videos for PPT
  • More Products for PPT
PowerPlugs
PowerPlugs
CrystalGraphics
Home About Us Terms and Conditions Privacy Policy Contact Us Send Us Feedback
Copyright 2021 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
taxus — Search results on PowerShow.com
Loading...